All Stories

  1. Coronavirus infection and depression as predictors of menstrual dysfunction in female students during the COVID-19 Pandemic
  2. Resolution of the council of experts on venous thromboembolic complications in obstetrics
  3. Venous thromboembolism associated with weak transient risk factors in young women: risk of late recurrence. An international cohort study
  4. Biomarkers of vascular well-being as risk factors for rosacea in perimenopausal women
  5. Clinical and anamnestic features of rosacea in women in perimenopausal period
  6. PARTICIPANTS OF THE FIBRINOLYSIS SYSTEM AS PREDICTORS OF MYOMATOUS NODES GROWTH RECURRENCE
  7. Venous Thromboembolism at Low Risk of Recurrence in Young Women: Stress and Violence Associated with Recurrence. An International Case-Control Study
  8. Allergic contact dermatitis in the beauty industry
  9. Neuraxial anesthesia in emergency vascular surgery in elderly and senile patients
  10. Intimate partner violence as a risk factor for venous thromboembolism in women on combined oral contraceptives: An international matched case-control study
  11. Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors
  12. ENHANCING THE EXPERIENCE OF INFERTILITY TREATMENT THROUGH INTRAUTERINE INSEMINATION IN ALTAI KRAI
  13. THE IMPACT OF ETHNICITY ON CLINICAL FEATURES OF PREECLAMPSIA
  14. Early diagnostics of prostate cancer based on a comprehensive analysis of risk factors
  15. Hemostatic imbalance underlying preterm delivery in COVID-19 convalescent patients
  16. Comparative assessment of effect of two methods of spinal anesthesia on central hemodynamic parameters in elderly and senile patients in emergency vascular surgery
  17. Is intimate partner abuse underestimated as a precipitating factor for venous thromboembolism in women?
  18. Menstrual function and mental health of medical students during the COVID-19 pandemic: a continuous cross-sectional study
  19. What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas?
  20. Markers of systemic endotheliosis in early-onset preeclampsia relapse
  21. Complications and outcomes of pregnancy in patients with antiphospholipid antibodies during various treatment methods
  22. Bleeding disorders associated with severity of respiratory failure in COVID-19 patients: a prospective observational study
  23. Maternal blood proteomics during relapse of early preeclampsia
  24. ADVANCING PLASMA D-DIMER LEVEL DETERMINATION: AN APPLICABILITY ANALYSIS FOR COVID-19 PATIENTS AT THE HOSPITAL STAGE
  25. Dysmenorhea in female medical students during the COVID-19 pandemic
  26. MORPHOLOGICAL CHARACTERISTICS OF SCAR TISSUE AFTER CESAREAN SECTION WITH UNFAVORABLE OUTCOMES
  27. Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.
  28. The Role of Vascular-Platelet Hemostasis Disturbances in the Genesis of Respiratory Failure in Patients with COVID-19
  29. The role of coagulation hemostasis for development of early-onset preeclampsia in low-risk patients
  30. Pregnancy after Combined Oral Contraceptive-Associated Venous Thromboembolism: An International Retrospective Study of Outcomes
  31. Predicting recurrence of uterine myoma after carrying out a selective uterine arteries embolization
  32. The prediction of different phenotypes of preeclampsia in the first trimester of pregnancy (two-center retrospective study)
  33. DELAYED ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH A HISTORY OF EARLY PRE-ECLAMPSIA AND FEATURES OF PREGRAVIDARY PREPARATION
  34. How high is the risk of thromboembolism in IVF?
  35. New risk factors for acute myocardial infarction in young men
  36. Features of the course of the gestational process with the carriage of genotypes F5L:G(1961)A and F2:G(20210)A and inheritance options
  37. The Role of Extracellular Vesicles of Various Origins in the Development of Preeclampsia
  38. Low molecular weight heparin prophylaxis for placenta-mediated complications in women with F2G20210A mutation
  39. Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity
  40. Clinical realization for different types of preeclampsia (results of a double-centre retrospective study)
  41. Duration of thromboprophylaxis with low-molecular-weight heparin after abdominal delivery in Factor V Leiden carriers
  42. Pregnancy Complications In G20210A Mutation Carriers Associated With High Prothrombin Activity
  43. Thrombotic events in rare kinds of genetic thrombophilias
  44. Prevention of post-radiation damage to the bladder with medicinal plants in patients with locally advanced forms of cervical cancer
  45. Predicting intrauterine fetal infection risk in extremely preterm and early preterm births induced by rupture of the amniotic membranes
  46. Great Obstetrical Syndromes In G20210a Mutation Carriers Associated With High Prothrombin Activity
  47. Possibilities of medicinal plants in accompanying therapy and rehabilitation of patients with malignant neoplasms of the cervix
  48. Gestational complications of the prothrombin G20210A mutation related to prothrombin activity
  49. Assessment of hemostasis in physiological pregnancy. Algorithms of examination in high risk groups. Guidelines (PROJECT), 2nd edition 
  50. Clinical and laboratory manifestations of the prothrombin gene mutation in women of reproductive age
  51. Clinical effects of intermittent pneumatic compression
  52. Phenotypic Manifestations of Prothrombin Gene Mutation, Genotype, in Women of Reproductive Age
  53. Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype)
  54. THE POSSIBILITIES OF MODERN TREATMENT OF PATIENTS WITH UTERINE FIBROIDS IN REPRODUCTIVE AGE
  55. The Role of the Acquired Risk Factors in the Development of Venous Thromboembolism in the Women of Reproductive Age Carrying Factor V Leiden
  56. Value of Color Doppler US in Evaluation of Deep Vein Thrombosis of Lower Limb
  57. Impact of lymphocyte therapy on blood fibrinolytic activity and immune responses in patients with a history of reproductive losses
  58. THROMBOPHILIAS IN OBSTETRICIAN AND GYNECOLOGICAL PRACTICE, HEPARIN PREVENTION
  59. Risk factors of the previa placenta formation
  60. Relationship between preeclampsia and SERPINE1 (PAI-1-675 G4/G5) gene polymorphism. Systematic review. A metaanalysis